The latest announcement is out from BioNano Genomics Inc (BNGO).
Bionano Genomics, Inc. has initiated a registered direct offering, securing an agreement with institutional investors to sell over 6.5 million shares and warrants that could potentially bring in $10 million in gross proceeds. The funds are earmarked for general corporate needs, including R&D, working capital, and debt repayment. Shares and warrants are priced at $1.145 and $1.144 respectively, with the offering set to close around April 8, 2024. This move represents a strategic step by the company to strengthen its financial position and invest in its future growth.
See more data about BNGO stock on TipRanks’ Stock Analysis page.
